
Regenerating neurons, restoring lives
Convalesce is developing a stem cell-based therapy for neurological conditions like Parkinson's disease. Their core innovation is AmGel, a brain-mimetic hydrogel matrix that improves stem cell survival by 300% post-transplantation and confines cells to the target area. The gel's nanoscale topography mimics the brain's extracellular matrix, guiding stem cell differentiation into target neuron types.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account